Xianling Wang

1PUBLICATIONS
19CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 13, 2024
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.

Jason J Luke, Karen Gelmon, Lillian L Siu

Pageof 1

Frequent Collaborators

1 joint publications

Jason J Luke

1 joint publications

Karen Gelmon

1 joint publications

Lillian L Siu

1 joint publications

Victor Moreno